Castle Biosciences, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €350.09M +9.3% -€32.67M -25.1% -9.3% +0.043 pp N/A N/A
    (estimated) €320.37M +9.8% -€43.63M -11.0% -13.6% +0.032 pp N/A N/A
    (estimated) €291.78M +∞% -€49.03M +2.6% -16.8% -0.17 pp €7.11M +545.7% 2.4% +0.024 pp
    (estimated) N/A -€47.80M +5.6% N/A €1.10M -89.5% N/A
    (estimated) €270.67M -4.4% -€45.27M -390.9% -16.7% -0.22 pp €10.48M -86.8% 3.9% -0.24 pp
    €283.24M +51.1% €15.56M -131.7% 5.5% +0.32 pp €79.49M +1,065.6% 28.1% +0.24 pp
    €187.47M +60.4% -€49.02M -14.4% -26.1% +0.23 pp €6.82M -122.2% 3.6% +0.30 pp
    €116.89M +45.7% -€57.27M +114.6% -49.0% -0.16 pp -€30.73M +132.4% -26.3% -0.098 pp
    €80.25M +50.2% -€26.69M +204.3% -33.3% -0.17 pp -€13.22M -206.0% -16.5% -0.40 pp
    €53.44M +20.8% -€8.77M -294.9% -16.4% -0.27 pp €12.47M +83.8% 23.3% +0.080 pp
    €44.24M +127.6% €4.50M -182.9% 10.2% +0.38 pp €6.78M -166.2% 15.3% +0.68 pp
    €19.44M +65.7% -€5.43M -48.5% -27.9% +0.62 pp -€10.25M +2.4% -52.7% +0.33 pp
    €11.73M -€10.55M -89.9% -€10.01M -85.3%

    Notifications